Product image of Lacosamide Mylan (Lacosamide) supplied by GNH India

Lacosamide Mylan

Active Ingredient:
Lacosamide
Origin:
EU

Lacosamide Mylan (Lacosamide)

Lacosamide, the active ingredient in Lacosamide Mylan, is an anticonvulsant presented as an oral tablet for oral use. It is used to treat partial‑onset seizures in patients with epilepsy.
GNH India supplies Lacosamide Mylan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Generics [uk] Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Lacosamide is an anticonvulsant that acts on neuronal sodium channels to control seizure activity.

  • Partial‑onset seizures: reduces the frequency of seizure episodes in patients with focal epilepsy.
  • Focal seizures: provides adjunctive seizure control when other therapies are insufficient.
  • Epilepsy (adjunctive therapy): improves overall seizure management as part of combination treatment.

How It Works

  • Lacosamide enhances the slow inactivation of voltage‑gated sodium channels, stabilizing hyper‑excitable neuronal membranes and decreasing repetitive neuronal firing, which helps to control seizure activity in the central nervous system.

Side Effects

Lacosamide may cause a range of adverse reactions.

Common Side Effects

  • Dizziness
  • Nausea
  • Fatigue
  • Headache

Serious or Rare Side Effects

  • Cardiac arrhythmia (e.g., PR‑interval prolongation)
  • Severe skin reactions such as Stevens‑Johnson syndrome
  • Suicidal thoughts or behavior

Precautions & Warnings

Before initiating therapy, consider the following precautions.

  • Renal impairment: assess renal function and adjust dose if necessary.
  • Hepatic impairment: monitor liver enzymes and consider dose modification.
  • Cardiac conduction disorders: avoid in patients with known PR‑interval prolongation.
  • Concomitant CYP3A4 inhibitors or inducers: monitor for altered plasma levels.
  • Pregnancy: risk unknown; prescribe only if benefit outweighs potential risk.
  • Store at below 25°C: keep in the original packaging, protect from moisture.

Avoid Interactions

Lacosamide can interact with several medicines; review patient medication lists.

Major Interactions (Avoid)

  • Strong CYP3A4 inhibitors (e.g., ketoconazole)
  • Strong CYP3A4 inducers (e.g., carbamazepine, phenytoin)
  • Other sodium‑channel blockers (e.g., lamotrigine, phenytoin)

Moderate Interactions (Monitor Closely):\n- Anticoagulants such as warfarin

  • Hormonal contraceptives
  • Alcohol consumption

Frequently Asked Questions

Lacosamide Mylan is used as an adjunctive therapy to control partial‑onset seizures in patients with epilepsy. It helps reduce seizure frequency when used with other antiepileptic drugs.

Lacosamide enhances the slow inactivation of voltage‑gated sodium channels, stabilizing neuronal membranes and decreasing abnormal neuronal firing that leads to seizures.

The dose of Lacosamide Mylan is individualized and set by the prescribing healthcare professional based on the patient’s condition, response, and tolerability.

The safety of lacosamide in pregnancy and lactation has not been fully established. It should be used only if the potential benefit justifies any potential risk to the fetus or infant.

Submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and import documentation.

Lacosamide’s unique mechanism—enhancing slow sodium‑channel inactivation—differs from many traditional antiepileptics that block fast sodium channels. This can provide additional seizure control for patients who do not respond adequately to other agents.

Store the tablets at temperatures below 25 °C in the original container, protecting them from moisture and direct sunlight. Keep out of reach of children.

Lacosamide Mylan is taken orally, usually with or without food, as directed by the prescriber. Swallow the tablet whole with a glass of water.

Serious risks include cardiac arrhythmias such as PR‑interval prolongation, severe skin reactions like Stevens‑Johnson syndrome, and the emergence of suicidal thoughts or behavior. Patients should be monitored for these events.

Patients with known severe cardiac conduction disorders, significant PR‑interval prolongation, or hypersensitivity to lacosamide or any tablet excipients should avoid using Lacosamide Mylan.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Lacosamide

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT